Discounted Cash Flow
Orthofix Medical Inc.
—
—
⚠ Cash flow predictability 33/100 (unstable) —
FCF YoY std dev 82%,
net income 83% (full history)
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $476.0m | $3.5m | $32.8m | 0.7% | $0.17 |
| 2017 | $503.9m (5.9%) | $7.2m (103.6%) | $44.9m (36.8%) | 1.4% (92.4%) | $0.34 (100.0%) |
| 2018 | $526.3m (4.4%) | $16.0m (121.9%) | $42.2m (-6.1%) | 3.0% (112.5%) | $0.73 (114.7%) |
| 2019 | $534.3m (1.5%) | $-33.1m (-306.1%) | $15.1m (-64.1%) | -6.2% (-303.0%) | $-1.51 (-306.8%) |
| 2020 | $472.3m (-11.6%) | $2.9m (108.8%) | $68.3m (351.0%) | 0.6% (110.0%) | $0.13 (108.6%) |
| 2021 | $539.5m (14.2%) | $-44.6m (-1624.8%) | $801.5k (-98.8%) | -8.3% (-1434.7%) | $-1.95 (-1600.0%) |
| 2022 | $535.2m (-0.8%) | $-22.9m (48.5%) | $-38.2m (-4868.4%) | -4.3% (48.1%) | $-0.98 (49.7%) |
| 2023 | $867.3m (62.1%) | $-175.9m (-666.6%) | $-123.1m (-222.2%) | -20.3% (-373.0%) | $-4.12 (-320.4%) |
| 2024 | $928.7m (7.1%) | $-146.4m (16.8%) | $-10.6m (91.4%) | -15.8% (22.3%) | $-3.30 (19.9%) |
| 2025 | $955.2m (2.9%) | $-107.1m (26.8%) | $-1.5m (85.9%) | -11.2% (28.9%) | $-2.33 (29.4%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
SEC filings report in EUR. Values above are converted to USD for comparison with the US-listed share price.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Net debt deduction: —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.